Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Aprepitant vs Ondansetron with Dexamethasone for PONV Prevention
NCT02021851Phase 4Completed
- Sponsor
- Yeditepe University Hospital
- Start
- Jul 2011
- Primary completion
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of aprepitant in postoperative nausea and vomiting (PONV) (2 arms), sponsored by Yeditepe University Hospital. Primary endpoint: Complete response at 24 hours. Started Jul 2011; status: completed.
02
Drugs
aprepitant
03
Conditions
postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on NCT02021851.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02021851.